New data from Columbia and other ECMO centers throughout the world show that more than 60% of severe COVID-19 patients who receive ECMO, a heart-lung life support machine, survive.
A new study reveals how P. aeruginosa bacteria—which cause many deaths worldwide from pneumonia—commandeer our immune defenses to thrive inside the lungs.
A mismatch between airway and lung size may explain why some nonsmokers get COPD and some heavy smokers do not, according to a new study from Columbia University.
A new study shows that smoking even a few cigarettes a day is harmful to lungs and that former smokers continue to lose lung function at a faster rate than never-smokers for decades after quitting.
Long-term exposure to air pollution, especially ozone, is associated with the development of emphysema, researchers at Columbia and other universities have found.
A new study from Columbia researchers provides robust evidence to support a simple, fixed ratio threshold for diagnosing chronic obstructive pulmonary disease (COPD).
A drug given to nearly 10 percent of all pregnant women to prevent severe respiratory ailments in preterm babies also reduces health care costs, according to a new study by Columbia researchers.
A clinical trial of ECMO for patients with severe respiratory distress resolves some questions about when to use the technology, but leaves others unanswered.
The internal anatomy of our lungs is surprisingly variable, and some variations are associated with a greater risk of chronic obstructive pulmonary disease, CUIMC researchers have found.